News stories about Quidel Corporation (NASDAQ:QDEL) have been trending somewhat positive recently, Accern Sentiment Analysis reports. Accern identifies negative and positive media coverage by reviewing more than twenty million blog and news sources. Accern ranks coverage of companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Quidel Corporation earned a news sentiment score of 0.07 on Accern’s scale. Accern also assigned media coverage about the company an impact score of 46.6048728124496 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the company’s share price in the next few days.
QDEL has been the topic of several research analyst reports. Zacks Investment Research downgraded Quidel Corporation from a “hold” rating to a “strong sell” rating in a research note on Saturday, July 29th. BidaskClub downgraded Quidel Corporation from a “strong-buy” rating to a “buy” rating in a research note on Sunday, July 16th. William Blair raised Quidel Corporation from a “market perform” rating to an “outperform” rating in a research note on Tuesday, July 18th. TheStreet downgraded Quidel Corporation from a “b-” rating to a “c” rating in a research note on Wednesday, July 26th. Finally, Barclays PLC lifted their price target on Quidel Corporation from $26.00 to $27.00 and gave the company an “overweight” rating in a research note on Wednesday, April 26th. One analyst has rated the stock with a sell rating, three have given a hold rating and four have issued a buy rating to the company. The company presently has a consensus rating of “Hold” and a consensus target price of $31.40.
Quidel Corporation (QDEL) traded up 0.43% during mid-day trading on Friday, hitting $32.61. The company’s stock had a trading volume of 132,775 shares. Quidel Corporation has a 52-week low of $18.25 and a 52-week high of $38.92. The firm has a 50 day moving average of $32.13 and a 200-day moving average of $25.45. The firm’s market cap is $1.09 billion.
Quidel Corporation (NASDAQ:QDEL) last announced its quarterly earnings data on Wednesday, July 26th. The company reported ($0.35) earnings per share for the quarter, missing the consensus estimate of ($0.17) by $0.18. Quidel Corporation had a negative net margin of 0.03% and a negative return on equity of 0.03%. The company had revenue of $38.30 million for the quarter, compared to analyst estimates of $41.91 million. During the same quarter in the prior year, the company posted ($0.11) EPS. Quidel Corporation’s revenue for the quarter was down 2.0% on a year-over-year basis. On average, equities research analysts expect that Quidel Corporation will post $0.28 EPS for the current fiscal year.
In other news, CEO Douglas C. Bryant sold 12,000 shares of the company’s stock in a transaction dated Friday, May 26th. The shares were sold at an average price of $24.90, for a total transaction of $298,800.00. Following the transaction, the chief executive officer now owns 296,493 shares in the company, valued at $7,382,675.70. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, SVP Michael Donald Jr. Abney sold 1,173 shares of the company’s stock in a transaction dated Friday, July 28th. The stock was sold at an average price of $33.83, for a total transaction of $39,682.59. The disclosure for this sale can be found here. Insiders have sold 227,388 shares of company stock worth $6,951,432 in the last quarter. Company insiders own 22.00% of the company’s stock.
ILLEGAL ACTIVITY WARNING: This news story was first reported by Community Financial News and is the sole property of of Community Financial News. If you are accessing this news story on another domain, it was stolen and reposted in violation of U.S. and international copyright and trademark law. The legal version of this news story can be accessed at https://www.com-unik.info/2017/08/19/quidel-corporation-nasdaqqdel-earning-somewhat-favorable-news-coverage-study-finds-updated-updated.html.
About Quidel Corporation
Quidel Corporation is engaged in the development, manufacturing and marketing of diagnostic testing solutions. These diagnostic testing solutions are separated into four product categories: immunoassays, molecular assays, virology and specialty products. The Company sells its products directly to end users and distributors, in each case, for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, universities, retail clinics, pharmacies and wellness screening centers.
What are top analysts saying about Quidel Corporation? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Quidel Corporation and related companies.